Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Skyline Champion, Atea Pharmaceuticals And Other Big Stocks Moving Lower On Tuesday

Published 30/05/2023, 15:58
Updated 30/05/2023, 17:10
© Reuters.  Skyline Champion, Atea Pharmaceuticals And Other Big Stocks Moving Lower On Tuesday

Benzinga - U.S. stocks traded mixed, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

  • Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) shares fell 10.6% to $4.18. Atea Pharmaceuticals' board unanimously rejected unsolicited proposal from Tang Capital Partners' Affiliate, Concentra Biosciences.
  • HUTCHMED (China) Limited (NASDAQ: HCM) shares tumbled 9.9% to $12.06.
  • Sana Biotechnology, Inc. (NASDAQ: SANA) fell 9% to $5.72.
  • Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) shares fell 8.3% to $2.9150. Lexicon Pharmaceuticals reported the FDA approval of INPEFA for the treatment of heart failure..
  • U.S. Silica Holdings, Inc. (NYSE: SLCA) dropped 8.3% to $11.32.
  • Weibo Corporation (NASDAQ: WB) dipped 8.2% to $14.03.
  • Skyline Champion Corporation (NYSE: SKY) declined 7.6% to $59.61 after the company reported mixed Q4 financial results.
  • RLX Technology Inc. (NYSE: RLX) fell 7.2% to $1.8750. RLX Technology recently reported a year-over-year decrease in first-quarter adjusted EPADS and sales results.
  • Genie Energy Ltd. (NYSE: GNE) dropped 7.1% to $14.48.
  • Comerica Incorporated (NYSE: CMA) dropped 6.8% to $36.34.
  • Carrols Restaurant Group, Inc. (NASDAQ: TAST) fell 6.8% to $5.17.
  • Marvell Technology, Inc. (NASDAQ: MRVL) fell 4.1% to $62.92. Marvell Technology EVP, Chief Operations Officer Chris Koopmans sold a total of 8,000 shares at an average price of $48.96. The company’s EVP, Storage Products Group Dan Christman also sold 53,732 shares of the company.

Read More: Nasdaq Tops 13,000; US House Prices Drop In March

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.